Royalty Payments; Royalty Reports. After the First Commercial Sale and for the remaining term of this Agreement, VIA shall submit with each payment of royalties to Roche a written royalty report (“Royalty Report”) covering sales of Licensed Product for each VIA fiscal quarter (currently ending on or about the last day of March, June, September, and December) with the following information provided on a country-by-country basis for the Major Market countries and for the rest of the world as a whole:
Appears in 4 contracts
Samples: And Commercialization Agreement, And Commercialization Agreement (Madrigal Pharmaceuticals, Inc.), Research, Development and Commercialization Agreement (Via Pharmaceuticals, Inc.)
